Despite a significant 43% surge in RITES stock in the year-to-date 2023, Elara Securities has reiterated its 'sell' call on the company, setting a target ...

Axis Securities, in its latest analysis, designates Aarti Drugs as the 'Top Pick of the Week,' underlining four compelling reasons for a 'buy' recommendation ...